Medicare Part D now has a $2,000 annual cap on drug costs in 2025, eliminating the donut hole. Learn how Extra Help, plan choices, and insulin pricing work for seniors on prescription meds.
Chronic insomnia isn't solved by sleep hygiene alone. Learn why CBT-I is the only evidence-based treatment that works long-term-and how to start it, stick with it, and finally get real sleep.
Explore how ropinirole affects daytime sleepiness in Parkinson's patients, review key studies, compare alternatives, and learn practical tips to stay alert.
Narrative medicine helps patients and providers understand how personal stories shape trust in medications. Learn how listening to patients' experiences can improve acceptance of generic drugs-even when science says they're identical.
HIV protease inhibitors can reduce the effectiveness of hormonal birth control, increasing pregnancy risk. Learn which methods are unsafe, which are reliable, and what to do if you're on antiretroviral therapy.
In my latest blog post, I discussed the crucial role of cycloserine in managing multidrug-resistant tuberculosis (MDR-TB). Cycloserine, an antibiotic, has become increasingly important in the treatment of MDR-TB, especially when other first-line medications are ineffective. This is because it targets the bacteria causing TB in a different way, thus overcoming resistance. However, it's essential to use cycloserine in combination with other antibiotics to ensure maximum effectiveness and minimize the risk of further resistance. Overall, cycloserine plays a vital role in the fight against MDR-TB, and ongoing research is crucial to optimize its use and develop new treatments.